Avantor, Inc.AVTREarnings & Financial Report
NYSE · Industrials · Laboratory Analytical Instruments
Avantor, Inc. is an American biotechnology, chemicals, and pharmaceutical company headquartered in Radnor, Pennsylvania. Established in 1904 as J.T. Baker, the company changed its name to Avantor in 2010. Avantor went public in 2019 and is now listed on the New York Stock Exchange under the symbol “AVTR”.
Top Holders
| Holder | % Owned | Shares | Change | As of |
|---|---|---|---|---|
| BlackRock, Inc. | 10.80% | 73.3M | ▲ +4.00pp | 2024-08-07 |
| S.S. OR | 10.10% | 68.7M | ▲ +1.10pp | 2024-08-09 |
| T. Rowe Price Investment Management, Inc. | 9.90% | 67.1M | ▼ -0.40pp | 2024-11-14 |
| The Vanguard Group | 9.66% | 65.3M | — | 2024-02-13 |
| T. ROWE PRICE ASSOCIATES, INC. | 2.90% | 19.5M | flat | 2024-02-16 |
Insider Transactions
Net 90d: +$2.40M · buys $2.40M / sells $0Range:
Action:
Role:
| Insider | Role | Action | ||||
|---|---|---|---|---|---|---|
| 2026-04-03 | Eck Steven W | SVP & Chief Accounting Officer | Grant | 31.6K | $0.00 | $0 |
| 2026-03-10 | MEHRA SANJEEV K | Director | Buy (open market) | 125.0K | $8.01 | $1.00M |
| 2026-02-19 | Brittany Hankamer | EVP, Chief HR Officer | Grant | 80.6K | $0.00 | $0 |
| 2026-02-19 | Mary Blenn | EVP, Chief Operating Officer | Grant | 236.0K | $0.00 | $0 |
| 2026-02-19 | Corey Walker | President, VWR Dist. & Servs. | Grant | 161.2K | $0.00 | $0 |
| 2026-02-19 | Emmanuel Ligner | President and CEO | Grant | 483.7K | $0.00 | $0 |
| 2026-02-19 | Claudius Sokenu | EVP, Chief Legal & Compliance | Grant | 80.6K | $0.00 | $0 |
| 2026-02-19 | Eck Steven W | SVP & Chief Accounting Officer | Grant | 48.9K | $0.00 | $0 |
| 2026-02-19 | Benoit Gourdier | EVP, Bioscience & Medtech | Grant | 134.4K | $0.00 | $0 |
| 2026-02-19 | Jones R. Brent | EVP, Chief Financial Officer | Grant | 161.2K | $0.00 | $0 |
1–10 of 12
Page 1 / 2